Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
about
Regulatory agencies hold the key to improving Cochrane reviews of drugsWhy the Cochrane Risk of Bias Tool Should Include Funding Source as a Standard ItemIndustry sponsorship and research outcomeNegativland - a home for all findings in psychologyImpact of reporting bias in network meta-analysis of antidepressant placebo-controlled trialsReporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic ReviewIncreasing value and reducing waste: addressing inaccessible researchStrategies for obtaining unpublished drug trial data: a qualitative interview studySPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsImpact of searching clinical trial registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analysesComparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic ProjectSearching for unpublished data for Cochrane reviews: cross sectional study.Value and usability of unpublished data sources for systematic reviews and network meta-analyses.Systematic review finds that study data not published in full text articles have unclear impact on meta-analyses results in medical researchThe 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines.How transparent are migraine clinical trials? Repository of Registered Migraine Trials (RReMiT).Identification of additional trials in prospective trial registers for Cochrane systematic reviewsInnovation and cross-fertilization in systematic reviews and meta-analysis: The influence of women investigators.Conflicts of interest and critiques of the use of systematic reviews in policymaking: an analysis of opinion articles.Blood pressure lowering efficacy of renin inhibitors for primary hypertension.Results availability for analgesic device, complex regional pain syndrome, and post-stroke pain trials: comparing the RReADS, RReACT, and RReMiT databases.Indacaterol for chronic obstructive pulmonary disease: systematic review and meta-analysisPreventive home visits for mortality, morbidity, and institutionalization in older adults: a systematic review and meta-analysis.Systematic Reviewers in Clinical Neurology Do Not Routinely Search Clinical Trials Registries.Ten Years after the International Committee of Medical Journal Editors' Clinical Trial Registration Initiative, One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional AnalysisPublic availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov.How do authors of systematic reviews deal with research malpractice and misconduct in original studies? A cross-sectional analysis of systematic reviews and survey of their authorsStandardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis.Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study.Clinical trials registries are underused in the pregnancy and childbirth literature: a systematic review of the top 20 journals.A systematic review of the outcomes reported in trials of medication review in older patients: the need for a core outcome set.Grey literature in systematic reviews: a cross-sectional study of the contribution of non-English reports, unpublished studies and dissertations to the results of meta-analyses in child-relevant reviews.Publication and non-publication of drug trial results: a 10-year cohort of trials in Norwegian general practice.Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review.On-the-Job Evidence-Based Medicine Training for Clinician-Scientists of the Next Generation.Non-publication of large randomized clinical trials: cross sectional analysis.Publication bias, with a focus on psychiatry: causes and solutions.Biomedical journals lack a consistent method to detect outcome reporting bias: a cross-sectional analysis.Issues relating to selective reporting when including non-randomized studies in systematic reviews on the effects of healthcare interventions.The evolution in registration of clinical trials: a chronicle of the historical calls and current initiatives promoting transparency.
P2860
Q24186305-FCBF502F-3F7E-47C1-A868-4386B8F524A3Q24201550-569023EC-3AE1-4833-BC36-42766057B6A6Q24202591-2F4F2E88-E1E3-4912-8251-A59CBA51FAB2Q24288901-F14C06BF-EBF0-4239-9F7D-B7745CE98741Q28482475-A9BC8995-4468-479B-B882-458233F9CD0BQ28554247-95A14590-54EF-4BB0-B665-AB22D00047CDQ28611347-58B64049-AA9C-488F-BC43-DC2DACDCC32FQ28681320-659E5392-2800-4461-9350-473F7C03572EQ28710019-4879BA0D-D611-4A94-AAC4-E05C6733F0A5Q30235881-01B5B11A-6723-4982-88F0-AEDE9F782410Q30490905-5879D1AC-5812-4D1B-AF23-BD659CCBA147Q30619697-38F55C32-FD28-4165-93F3-1BECD6E951B4Q31133808-F1BE47D9-BC4F-4AE3-8EAA-8F0A9A564CD2Q33602408-7C1447DF-6123-4ACD-95AF-2EC3C2D23940Q34279280-838C1236-6FE1-42C5-9CEF-553F593AAA9BQ34303798-FB44F752-A02E-4992-A31C-7BE69E98A382Q34391049-B7F38C7F-2875-44E6-BE6B-C8E7CEBB1410Q34481673-6FEF84EB-4C69-45C6-94B7-E732F247474BQ34560163-87F575CB-C673-4585-AF7B-7A24BA65E048Q34681386-DAEDBDB4-7FEA-4FDD-841F-2366F588DE48Q34790930-CD78E893-86CE-4A39-94CD-C3304AD588BCQ34962838-B11115DB-0CCA-48B1-9DA8-F7E27957032EQ35119105-A4F554E6-20F3-49D2-84CC-791F7F4BDB51Q35725894-9537EA57-8017-43C8-9DB3-63D910E67131Q35886881-486834C4-6841-4D3E-A997-C27C36AF0DA6Q35906626-D64B25FA-E41D-4581-B2C2-AA4941B77530Q35943880-C13CC6FA-B83B-4A0A-9DE4-FC193C58988DQ35977529-343099E8-EBC4-447E-8022-2C5A4FC18C54Q36027782-AE783E83-34F2-4E59-A7C0-692F344AACDBQ36171533-5808C225-2D20-4FC1-8024-AF9108101150Q36205093-77F3E5D5-7987-4C6F-B899-6C301C629D13Q36350256-B28A5C23-5FF9-428E-84DF-C5F17C982011Q36819100-EC395884-8694-49EC-9FDB-6760856E699DQ37149764-8E1AAE10-2E6C-49CD-8C29-0A36D8F90E03Q37236087-E7BABF3F-1B51-4C13-A0E5-DC70C56FECE0Q37266348-F46517CE-2CBB-4926-AF37-6A6DB230D90DQ38108574-96D379C0-3CEF-48B1-898D-1B97B273B909Q38211806-1039B216-A3FB-42E1-99E8-32C5F9E7DDD5Q38520309-0E833694-39B2-42C0-B4B3-C4DAA8417C54Q38560675-917E536D-F56B-4736-B9BD-365789762CBE
P2860
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
@ast
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
@en
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
@nl
type
label
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
@ast
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
@en
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
@nl
prefLabel
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
@ast
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
@en
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
@nl
P356
P1433
P1476
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
@en
P2093
P356
10.1136/BMJ.D7202
P407
P577
2012-01-03T00:00:00Z